Thyroid function in newly diagnosed HIV-infected patients

Toxicology and Industrial Health

Volumn 30, Issue 10, 2014, Pages 919-925

  Noureldeen, Amani Fh ^a,b   Qusti, Safaa Y ^a   Khoja, Gelan Ms ^a,c  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Ain Shams University   (Egypt)

^c KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

Author keywords

Endocrine dysfunction; hyperthyroidism; thyroid abnormality; thyroid disorder; thyroid stimulating hormone

Indexed keywords

ANTITHYROID PEROXIDASE; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HIV ELISA KIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; THYROID GLAND; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; YOUNG ADULT;

EID: 84911407634     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233712466133     Document Type: Article

References (32)

1. Ankri A, Bonmarchand M, Coutellier A et al. (1999) Antiphospholipid antibodies are an epiphenomenon in HIV-I. Journal of Pediatric Endocrinology and Metabolism 13: 1282–1283.
2. Arnsten JH, Freeman R, Howard AA et al. (2007) Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21: 617–623.
3. Beltran S, Lescure CJ, Esper IE et al. (2006) Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Hormone Research 66: 21–26.
4. Beltran S, Lescure FX, Desailloud R et al. (2003) Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clinical Infectious Diseases 37: 579–783.
5. Botella-Carrtero JI, Pados A, Manzano L et al. (2005) The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with different thyroid carcinoma before and during thyroxin withdrawal. European Journal of Endocrinology 153: 223–230.
6. Calza L, Manfredi R, Chiodo F et al. (2002) Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 31: 361–363.
7. Casau NC (2005) Perspective on HIV infection and aging: emerging research on the horizon. Clinical Infectious Diseases 41: 855–863.
8. Collazos J, Ibarra S, Mayo J (2003) Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: evidence of an interrelation between the thyroid axis and the immune system. AIDS 17: 763–765.
9. Dobs AS, Dempsey MA, Ladenson PW et al. (1998) Endocrine disorders in men infected with human immunodeficiency virus. American Journal of Medicine 84: 611–616.
10. Dupont WD, Plummer WD (1990) Power and sample size calculations: a review and computer program. Controlled Clinical Trials 11: 116–128.
11. Friis Moller N, Sabin CA, Weber R et al. (2003) Combination of antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine 349: 1993–2003.
12. Grappin M, Piroth L, Verges B et al. (2000) Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 14: 1070–1072.
13. Grunfeld C, Pang M, Doerrier W et al. (1993) Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism 42: 1270–1276.
14. Hoffmann JC, Brown TT (2007) Thyroid function abnormalities in HIV-infected patients. Clinical Infectious Diseases 45: 488–494.
15. Jain G, Devpura G, Gupta BS (2009) Abnormalities in the thyroid function test as surrogate marker of advancing HIV infection in infected adults. Journal of Association of Physicians of India 57: 508–510.
16. Klecha AJ, Genaro AM, Gorelik G et al. (2006) Integrative study of hypothalamus-pitutary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. Journal of Endocrinology 189: 45–55.
17. Klecha AJ, Genaro AM, Lysionek AE et al. (2000) Experimental evidence pointing to the bidirectional interaction between the immune system and the thyroid axis. International Journal of Immunopharmacology 22: 491–500.
18. Komorowski J, Stepien H, Pawilowski M et al. (1993) The evidence of thyroliberin / triiodothyronine control of TSH secretary response from human peripheral blood monocytes cultured in vittro. Neuropeptides 25: 31–34.
19. Lin HY, Martino LJ, Wilcox BD et al. (1998) Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. Journal of Immunology 16: 843–849.
20. Madeddu G, Spanu A, Chessa F et al. (2006) Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy. Clinical Endocrinology (Oxford) 64: 375–383.
21. Madge S, Smith C, Lamp F et al. (2006) No association between HIV disease and its treatment and thyroid function. HIV Medicine 7(supp 1): 23 abstract p49.
22. Marik PE, Kiminyo K, Zaloga GP et al. (2002) Adrenal insufficiency in critically ill patients with human immunodeficiency virus. Critical Care Medicine 30: 1267–1273.
23. Meena LP, Rai M, Singh SK et al. (2011) Endocrine changes in male HIV patients. Journal of Association of Physicians of India, 59: 2–3.
24. Merenich JA, McDemott MT, Asp AA et al. (1990) Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. Journal of Clinical Endocrinology and Metabolism 70: 566–571.
25. Montero A, Giovannoni AG, Fernandez MA et al. (1998) Autoantibodies in immunodeficiency virus-infected patients with and without concurrent hepatitis C infection. Arthritis and Rheumatism 41: 2077–2080.
26. Olivieri A, Sorcini M, Battisti P et al. (1993) Thyroid function related with the progression of human immunodeficiency virus infection. Journal of Endocrinology Investigation 16: 407–413.
27. Quirino T, Bongiovannt M, Ricci E et al. (2003) Hypothyroidism in HIV-infected patients who have or have not received HAART. Clinical Infectious Diseases 38: 596–597.
28. Raffi F, Brisseau JM, Planchon B et al. (1991) Endocrine function in 98 HIV–infected patients: a prospective study. AIDS 5: 729–733.
29. Viard JP, Chabre H, Bach JF et al. (1994) Autoantibodies to nucleosomes in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 7: 1286–1287.
30. Vinayagamoorthi R, Koner BC, Kavitha S et al. (2005) Potentiation of humoral immune response and activation of NF-kappa B pathway in lymphocytes in experimentally induced hyperthyroid rats. Cellular Immunology 238: 56–60.
31. Yen PM (2001) Phsyological and molecular basis of thyroid hormone action. Physiological Reviews 81: 1097–1142.
32. Wiener M, Lo Y, Klein RS (2008) Abnormal thyroid function in older men with or at a risk for HIV infection. HIV Medicine 9: 544–549.